HTA Database - Search Results

Sort by Relevance

Search Results [1398 Hits] Selected Records [0 Hits] [Clear]

Year	Source	Title
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Carotid echo doppler for plaque area measurement in cardiovascular risk stratification]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Virtual hysterosalpingograghy to evaluate the uterus and tubes patency]
2011	Institute for Clinical Effectiveness and Health Policy (IECS)	[Real time intraoperative magnetic resonance imaging monitoring]
2011	Committee for New Health Technology Assessment (CNHTA)	[C-11-acetate positron emission tomography, positron emission tomography/computed tomography]
2011	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Criteria for appropriate use of FDG-PET in esophageal cancer
2011	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Criteria for appropriate use of FDG-PET in colorectal cancer
2011	National Institute for Health and Care Excellence (NICE)	MiraQ for assessing graft flow during coronary artery bypass graft surgery. NICE medical technologies guidance 8
2011	Institut national d'excellence en sante et en services sociaux (INESSS)	[Computed tomography and its carcinogenic effects in children and youth in Québec]
2011	Basque Office for Health Technology Assessment (OSTEBA)	[Digital mammograms in breast cancer screening. Assessment of their efficiency and inclusion in the Early Breast Cancer Detection Programme of the Basque Country]
2011	NIHR Health Technology Assessment programme	Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation
2011	NIHR Health Technology Assessment programme	VenUS III: a randomised controlled trial of therapeutic ultrasound in the management of venous leg ulcers
2011	The Swedish Council on Health Technology Assessment (SBU)	Computed tomography for suspected coronary artery disease
2011	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Shoulder pain: appropriateness use of diagnostic imaging tests]
2011	NIHR Health Technology Assessment programme	The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews, registry database analyses and economic evaluation
2011	Haute Autorite de sante (HAS)	[MRI-guided vacuum-assisted breast biopsy (VABB)]
2011	NIHR Health Technology Assessment programme	The value of FDG positron emission tomography/computerised tomography (PET/CT) in pre-operative staging of colorectal cancer: a systematic review and economic evaluation
2011	Health Council of the Netherlands Gezondheidsraad (GR)	Population screening act: prostate cancer screening using MRI
2011	HAYES, Inc.	Near-infrared spectroscopy (INVOS cerebral/somatic oximeter) (Covidien) for adult cerebral indications
2011	HAYES, Inc.	Computer-Aided Detection (CADe) and Computer-Aided Diagnosis (CADx) for mammography
2011	National Institute for Health and Care Excellence (NICE)	The EOS 2D/3D imaging system. NICE diagnostics guidance 1
2011	The Swedish Council on Health Technology Assessment (SBU)	[Computer-Aided Detection (CAD) in mammography screening]
2011	National Institute for Health and Care Excellence (NICE)	Magnetic resonance image-guided transcutaneous focused ultrasound for uterine fibroids. NICE interventional procedures guidance 413
2011	NIHR Horizon Scanning Centre (NIHR HSC)	Aixplorer ultrasound machine for evaluating women with suspected breast cancer
2011	HAYES, Inc.	Pipeline embolization device (ev3 Inc.) for treatment of intracranial aneurysms
2011	HAYES, Inc.	Stereotaxis niobe magnetic navigation system (Stereotaxis Inc.) for catheter ablation of atrial fibrillation and other arrhythmias
2011	HAYES, Inc.	Ultrasound-Guided Foam Sclerotherapy (UGFS) for varicose veins
2011	HAYES, Inc.	Computer-aided detection of pulmonary embolism
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Positron emission tomography (PET) in head and neck tumours]
2011	HAYES, Inc.	Neuronavigation for intracranial biopsy and intracranial surgery
2011	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Positron emission tomography (PET) in malignant melanoma]
2011	HAYES, Inc.	Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for detection of recurrent ovarian cancer
2011	HAYES, Inc.	Positron Emission Tomography (PET) and Combined Positron Emission Tomography-Computed Tomography (PET-CT) for diagnosis and management of soft tissue sarcoma
2011	HAYES, Inc.	Full-field digital mammography for breast cancer screening
2010	National Institute for Health and Care Excellence (NICE)	Endobronchial ultrasound-guided transbronchial biopsy for peripheral lung lesions. NICE interventional procedures guidance 337
2010	Finnish Office for Health Care Technology Assessment (Finohta)	[18Fluorodeoxyglucose positron emission tomography in the assessment of patients with potentially curable cancer]
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	[Positron emission tomography (PET): diagnostic usefulness and indications]
2010	HAYES, Inc.	Quantitative computed tomography for bone mineral density
2010	Institute of Health Economics (IHE)	Routine preoperative electrocardiogram and chest x-ray prior to elective surgery in Alberta, Canada
2010	Finnish Office for Health Care Technology Assessment (Finohta)	[Fluorescence cystoscopy in diagnosis and management of superficial bladder cancer]
2010	HAYES, Inc.	Routine ultrasound examination in low-risk pregnancy
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Positron emission tomography for epilepsy: clinical effectiveness and guidelines
2010	Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA)	[Extracorporeal High-Intensity Focused Ultrasound (HIFU) in solid tumours]
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening programs for asymptomatic unruptured intracranial aneurysms: review of clinical effectiveness, cost-effectiveness, and evidence-based guidelines
2010	HAYES, Inc.	Eovist (Bayer Schering Pharma AG) contrast agent for magnetic resonance imaging of the liver
2010	HAYES, Inc.	Computed Tomography (CT)-guided lung biopsy with the superDimension i-Logica System (superDimension Inc.)
2010	Andalusian Health Technology Assessment Area (AETSA)	[Confocal microscopy in ophthalmology: Report summary of emergent technology]
2010	Medical Advisory Secretariat (MAS)	CT and MRI scans in the evaluation of chronic headaches
2010	Medical Advisory Secretariat (MAS)	Cancer screening with digital mammography for women at average risk of breast cancer or MRI for women at high risk
2010	Andalusian Health Technology Assessment Area (AETSA)	[4D Ultrasound]
2010	HAYES, Inc.	Eovist (Bayer Schering Pharma AG) contrast agent for magnetic resonance imaging of the liver
2010	Medical Advisory Secretariat (MAS)	The relative cost-effectiveness of five non-invasive cardiac imaging technologies for diagnosing coronary artery disease in Ontario
2010	Agence d'évaluation des technologies et des modes d'intervention en santé (AETMIS)	[Population ultrasound screening for abdominal aortic aneurysms]
2010	The Swedish Council on Health Technology Assessment (SBU)	[Early and focused ultrasonography in physical trauma]
2010	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Cerecyte (bioactive) coils for the treatment of intracranial aneurysms
2010	HAYES, Inc.	Positron emission tomography (PET) and combined positron emission tomography-computed tomography (PET-CT) for breast cancer detection
2010	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	BodyTite radiofrequency-assisted liposuction
2010	Committee for New Health Technology Assessment (CNHTA)	[18-f-sodium fluoride (18-f-naf) bone positron emission tomography, positron emission tomography/computed tomography]
2010	Committee for New Health Technology Assessment (CNHTA)	[Intraoperative computed tomography for neuronavigation in neurological surgery]
2010	Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S)	Image-guided intensity-modulated radiotherapy
2010	Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR)	Portable computed tomography (CT) for the study of diagnostic imaging in specialised areas or setting
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[Endoscopic tri-modal imaging for improved detection of early neoplasia in the gastrointestinal tract]
2010	Committee for New Health Technology Assessment (CNHTA)	[Autofluorescence image(endoscopy)]
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[Evaluation of the potential of real-time 3-dimensional echocardiography in the assessment of right ventricular function in adult congenital heart disease: comparison of RT-3D echo with MRI]
2010	NIHR Health Technology Assessment programme	A systematic review of positron emission tomography (PET) and positron emission tomography/computed tomography (PET/CT) for the diagnosis of breast cancer recurrence
2010	NIHR Health Technology Assessment programme	Multi-centre randomised controlled trial examining the cost-effectiveness of contrast-enhanced high field magnetic resonance imaging in women scheduled for wide local excision (COMICE)
2010	Medical Advisory Secretariat (MAS)	Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease
2010	Medical Advisory Secretariat (MAS)	Single photon emission computed tomography for the diagnosis of coronary artery disease
2010	Secretaria de Ciencia, Tecnologia e Insumos Estrategicos, Departamento de Ciencia e Tecnologia (DECIT-CGATS )	[BRATS 11: Positron Emission Tomography (PET) in the diagnosis, staging and restaging of patients with colorectal cancer]
2010	Medical Advisory Secretariat (MAS)	64-slice computed tomographic angiography for the diagnosis of intermediate risk coronary artery disease
2010	Medical Advisory Secretariat (MAS)	Cardiac magnetic resonance imaging for the diagnosis of coronary artery disease
2010	Medical Advisory Secretariat (MAS)	Non-invasive cardiac imaging technologies for the assessment of myocardial viability
2010	Blue Cross Blue Shield Association (BCBS)	Special report: positron emission tomography for the indication of post-treatment surveillance of cancer
2010	HAYES, Inc.	Breast-Specific Gamma Imaging (BSGI) using the Dilon 6800 gamma camera (Dilon Technologies Inc.)
2010	Institute for Clinical Effectiveness and Health Policy (IECS)	Digital dermoscopy in the diagnosis of melanoma
2010	Penn Medicine Center for Evidence-based Practice (CEP)	Guidelines for care after percutaneous coronary intervention (PCI)
2010	Haute Autorite de sante (HAS)	[Virtual colonoscopy: meta-analysis of diagnostic accuracy, indications and conditions of use]
2010	Haute Autorite de sante (HAS)	[Cervical length measurement with transvaginal ultrasonography to predict spontaneous preterm birth]
2010	Penn Medicine Center for Evidence-based Practice (CEP)	CT for acute chest pain
2010	Haute Autorite de sante (HAS)	[Place of Breast MRI in the pre-treatment locoregional spread assessment of breast cancer]
2010	Quality Improvement Scotland (NHS QIS )	Portable bladder ultrasound scanners
2010	Unidad de Evaluacion de Tecnologias Sanitarias (UETS)	[Appropriate use of diagnostic imaging technologies in primary and secondary care : ultrasonography in breast pathology]
2010	Medical Advisory Secretariat (MAS)	Neuroimaging for the evaluation of chronic headaches : an evidence-based analysis
2010	Adelaide Health Technology Assessment (AHTA)	The role of scintimammography in the diagnosis of breast cancer
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Positron emission tomography for cardiovascular disease: a review of the clinical effectiveness
2010	Canadian Agency for Drugs and Technologies in Health (CADTH)	Positron emission tomography (PET) in oncology: a systematic review of clinical effectiveness and indications for use
2010	Penn Medicine Center for Evidence-based Practice (CEP)	Comparative effectiveness of thermometry devices
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[General ultrasound screening for developmental dysplasia of the hip at three months of age: an implementation study]
2010	The Netherlands Organisation for Health Research and Development (ZonMw)	[Predicting efficient implementation and costs; ultrasound screening for developmental dysplasia of the hip]
2010	Medical Services Advisory Committee (MSAC)	Assessment of liver iron by R2 - Medical Resonance Imaging (MRI) data analysis
2010	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Osteodensitometry in primary and secondary osteoporosis]
2010	Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG)	[Positron emission tomography (PET) in high-grade malignant glioma (grades III and IV)]
2010	Adelaide Health Technology Assessment (AHTA)	MRI compatible dual chamber pacemaker
2010	Adelaide Health Technology Assessment (AHTA)	MRI-safe incubator for premature infants
2010	Adelaide Health Technology Assessment (AHTA)	Hand-held portable mini ultrasounds for applications including emergency rooms and ambulances
2010	Adelaide Health Technology Assessment (AHTA)	Screening for lung cancer utilising computed tomography (CT)
2010	Adelaide Health Technology Assessment (AHTA)	Scintimammograms or breast-specific gamma imaging (BSGI) for the evaluation of disease spread in women diagnosed with breast cancer
2010	Medical Advisory Secretariat (MAS)	Non-invasive cardiac imaging technologies for the diagnosis of coronary artery disease: a summary of evidence-based analyses
2010	HAYES, Inc.	Epiaortic ultrasound for assessing atherosclerosis in the ascending aorta
2010	Medical Advisory Secretariat (MAS)	Positron emission tomography (PET) for the assessment of myocardial viability
2010	Medical Advisory Secretariat (MAS)	Magnetic resonance imaging (MRI) for the assessment of myocardial viability